-40.8%
BMNR vs MRNA
+511.3%
-552.1%
-78.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.6% | -2.2% | -3.4% | -5.4% |
| 7D | +4.9% | +5.5% | -0.6% | +4.3% |
| 30D | +35.5% | +158.7% | -123.2% | +11.3% |
| 3M | +39.6% | +182.1% | -142.6% | +9.0% |
| 6M | +18.2% | +151.8% | -133.6% | -4.8% |
| YTD | -8.0% | +393.6% | -401.6% | -39.4% |
| 1Y | -40.8% | +499.5% | -540.3% | -59.3% |
| All | -40.8% | +511.3% | -552.1% | -59.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling